Quick Answer
TransMedics Group, Inc. reported Gross Profit of $362.81 million for fiscal year 2025.
TransMedics Group, Inc. Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2025 | $362.81M | +38.4% |
| 2024 | $262.08M | +70.1% |
| 2023 | $154.09M | +136.1% |
| 2022 | $65.27M | +208.5% |
| 2021 | $21.16M | +27.2% |
| 2020 | $16.64M | +20.0% |
| 2019 | $13.86M | +141.8% |
| 2018 | $5.73M | — |
Quarterly Gross Profit
| Quarter Ending | Gross Profit | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $84.58M | +39.0% | -12.4% |
| June 30, 2025 | $96.59M | +39.5% | +9.5% |
| March 31, 2025 | $88.23M | +47.1% | +45.0% |
| September 30, 2024 | $60.84M | +49.6% | -12.2% |
| June 30, 2024 | $69.26M | +88.5% | +15.5% |
| March 31, 2024 | $59.96M | +108.4% | +47.5% |
| September 30, 2023 | $40.66M | +124.5% | +10.7% |
| June 30, 2023 | $36.74M | +156.0% | +27.7% |
- TransMedics Group, Inc. showed an increase of +38.4% in Gross Profit compared to the prior fiscal year.
- Over the 2018–2025 period, TransMedics Group, Inc.’s gross profit has grown by 6227.3% (from $5.73 million to $362.81 million).
- The most recent figure is from TransMedics Group, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: